Top

Reactions Weekly

Published in:

01-11-2022 | Ramucirumab | Case report

Antineoplastics

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Cordova-Delgado M, et al. Proteogenomic analysis in an early onset diffuse gastric cancer patient revealed alterations in PIK3R1, TP53, SMAD4 and a potential role of the PI3K-AKT and EGFR pathways: A case report. Journal of Gastrointestinal Oncology 13: 2057-2064, No. 4, Aug 2022. Available from: URL: https://jgo.amegroups.com/article/view/65385/html

Title: Antineoplastics
Lack of efficacy: case report
Publication date: 01-11-2022
Publisher: Springer International Publishing
Keywords: Ramucirumab
Gastric Cancer
Gastric Cancer
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-26870-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Antipsychotics

Fluoxetine/sertraline

Antineoplastics

Tozinameran

Nafcillin/prednisone/sarilumab

Prednisolone